Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health 2022
Ahead of World Digestive Health 2022, Italian pharmaceutical group Alfasigma is proud to announce the launch of its new diagnostic drug Lumeblue™ (per-oral methylene blue). This latest innovation is...
Read more